Metropolis Healthcare Limited
Morgan Stanley bought 5,25,500 shares of Metropolis Healthcare Limited for ₹29.64 Cr at ₹564.00 apiece in a block deal.
One of India's leading diagnostics companies, Metropolis Healthcare operates an extensive chain of diagnostic centres providing pathology and radiology services across multiple regions. The company maintains a widespread presence in India, South Asia, Africa, and the Middle East, offering comprehensive laboratory testing and imaging solutions to patients and healthcare providers. Its network focuses on delivering accurate diagnostics and quality healthcare services through modern facilities and trained professionals.
US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.